“The objective of the study is to measure the epidemiology and drug use with patients affected by ITP. According to the study, ITP was equal to 262 cases / million assisted. About two thirds of the patients were treated with corticosteroid drugs and, among these, the majority had an exposure exceeding three months of therapy ”. This was stated by Luca Degli Esposti, President of CliCon Health, Economics and Outcomes Research, on the sidelines of the event “Primary Immune Thrombocytopenia: changing the approach to change your life”, promoted by Inrete with the non-conditioning contribution of Novartis.
!function(f,b,e,v,n,t,s)
{if(f.fbq)return;n=f.fbq=function(){n.callMethod?
n.callMethod.apply(n,arguments):n.queue.push(arguments)};
if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version=’2.0′;
n.queue=[];t=b.createElement(e);t.async=!0;
t.src=v;s=b.getElementsByTagName(e)[0];
s.parentNode.insertBefore(t,s)}(window, document,’script’,
‘https://connect.facebook.net/en_US/fbevents.js’);
fbq(‘init’, ‘415374439673532’);
fbq(‘track’, ‘PageView’);
Read Also
- Called fat products, healthy Jul 20, 2020
- The most useful kind of bread Jul 15, 2020
- Jurassic Park: The Doctor Collector welcome box is soon out of stock May 21, 2022
- Do you have to stop using the mask? Dr. Leana Wen explains May 30, 2021
- Now, “In Treatment 4”: plot and cast of the fourth season Jul 16, 2021
- Heat does not kill coronavirus, and summer warming will not stop the pandemic — scientists warn Apr 20, 2020
- New York launches cyber defense center in the heart of Manhattan Jul 9, 2021
